Profile
Ms. Alexandra Goll is General Partner at TVM Capital GmbH which she joined in 1998.
She is also Mitglied des Vorstands at Addex Pharmaceuticals SA. She is on the Board of Directors at Biovertis AG, Arrow Therapeutics Ltd., Cerenis Therapeutics Holding SA, and Albireo AB. Dr. Goll also served on the board at Pharmasset, Inc.
Prior to her affiliation with TVM, Dr. Goll was the Global Business Leader for HIV and CMV, and was responsible for strategic marketing and business development for Virology at Roche Ltd. in Basel.
She had been involved in clinical development and managing commercialisation strategies of several products.
Dr. Alexandra Goll holds a degree in pharmacy from the Free University of Berlin, and wrote her doctoral dissertation in natural sciences at Philipps University of Marburg.
Alexandra Goll active positions
| Companies | Position | Start |
|---|---|---|
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Develops small molecule drugs against proprietary microbial antigens | Director/Board Member | - |
Former positions of Alexandra Goll
| Companies | Position | End |
|---|---|---|
| HEIDELBERG PHARMA AG | Director/Board Member | 13/12/2011 |
| ADDEX THERAPEUTICS LTD | Corporate Officer/Principal | 16/04/2008 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Director/Board Member | 01/11/2007 |
| IDENIX PHARMACEUTICALS INC | Director/Board Member | 30/04/2003 |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | - |
Training of Alexandra Goll
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and other infectious diseases caused by hepatitis and human immunodeficiency virus | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
Heidelberg Pharma AG
Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Addex Therapeutics Ltd.
Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
Biovertis AG
Biovertis AG Pharmaceuticals: MajorHealth Technology Develops small molecule drugs against proprietary microbial antigens | Health Technology |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABIONYX Pharma SA
ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
Albireo Ltd.
Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
- Stock Market
- Insiders
- Alexandra Goll
















